IRON
Price
$54.50
Change
+$0.37 (+0.68%)
Updated
Jun 27 closing price
Capitalization
1.89B
39 days until earnings call
VYNE
Price
$1.42
Change
-$0.20 (-12.35%)
Updated
Jun 27 closing price
Capitalization
23.66M
Interact to see
Advertisement

IRON vs VYNE

Header iconIRON vs VYNE Comparison
Open Charts IRON vs VYNEBanner chart's image
Disc Medicine
Price$54.50
Change+$0.37 (+0.68%)
Volume$1.06M
Capitalization1.89B
VYNE Therapeutics
Price$1.42
Change-$0.20 (-12.35%)
Volume$1.24M
Capitalization23.66M
IRON vs VYNE Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. VYNE commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and VYNE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IRON: $54.50 vs. VYNE: $1.42)
Brand notoriety: IRON and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 278% vs. VYNE: 211%
Market capitalization -- IRON: $1.89B vs. VYNE: $23.66M
IRON [@Biotechnology] is valued at $1.89B. VYNE’s [@Biotechnology] market capitalization is $23.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 1 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 1 green, 4 red.
According to our system of comparison, VYNE is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 5 TA indicator(s) are bullish while VYNE’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 5 bullish, 4 bearish.
  • VYNE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IRON is a better buy in the short-term than VYNE.

Price Growth

IRON (@Biotechnology) experienced а +5.60% price change this week, while VYNE (@Biotechnology) price change was +59.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($1.89B) has a higher market cap than VYNE($23.7M). IRON YTD gains are higher at: -14.038 vs. VYNE (-57.612). VYNE has higher annual earnings (EBITDA): -45.44M vs. IRON (-114.41M). IRON has more cash in the bank: 695M vs. VYNE (50.3M). VYNE has less debt than IRON: VYNE (63K) vs IRON (30.6M). VYNE has higher revenues than IRON: VYNE (605K) vs IRON (0).
IRONVYNEIRON / VYNE
Capitalization1.89B23.7M7,966%
EBITDA-114.41M-45.44M252%
Gain YTD-14.038-57.61224%
P/E RatioN/A0.71-
Revenue0605K-
Total Cash695M50.3M1,382%
Total Debt30.6M63K48,571%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONVYNE
RSI
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDLB13.980.24
+1.75%
Ponce Financial Group
FOUR98.220.18
+0.18%
Shift4 Payments
MFC31.99-0.09
-0.28%
Manulife Financial Corp
WTTR8.77-0.06
-0.68%
Select Water Solutions
NEPH3.86-0.38
-8.96%
Nephros

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with CGON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.68%
CGON - IRON
52%
Loosely correlated
-0.46%
SYRE - IRON
50%
Loosely correlated
-4.99%
IDYA - IRON
50%
Loosely correlated
-4.13%
KMSTF - IRON
49%
Loosely correlated
N/A
CRNX - IRON
48%
Loosely correlated
-0.10%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with EYPT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
-12.35%
EYPT - VYNE
38%
Loosely correlated
-7.04%
IRON - VYNE
37%
Loosely correlated
+0.68%
ARCT - VYNE
34%
Loosely correlated
-7.49%
SYRE - VYNE
33%
Loosely correlated
-4.99%
ELVN - VYNE
33%
Loosely correlated
-3.95%
More